Archive · 6 Oct 2026
How Bone Signals May Connect to Blood Sugar Control
Bones do more than hold up the body.
They are active and constantly renew themselves.
Some bone cells make a protein called osteocalcin.
Scientists are studying whether it helps the body manage insulin and blood sugar.
Early studies in animals and cells suggest it might, but the evidence in people is not yet clear.
Diabetes can also affect bone strength, even when a bone-density test looks normal.
Shared factors such as age, activity, diet, and body weight may affect both bones and blood sugar.
Exercise that loads bones, good nutrition, and blood sugar management can support both.
Osteocalcin is still being studied and is not an established blood sugar treatment.
Bone-forming cells produce osteocalcin, which researchers have proposed may affect insulin secretion and sensitivity.
Animal and cell studies suggest osteocalcin could influence glucose metabolism, but evidence in humans is less definitive.
The clinically relevant form of osteocalcin and how it should be measured remain uncertain.
People with type 2 diabetes can face higher fracture risk, even when bone mineral density is normal or relatively high.
Exercise, adequate nutrition, healthy weight management, and good blood sugar control can support both bone and metabolic health.
- Who
- Dr Raju Vaishya, senior consultant orthopaedic and joint replacement surgeon at Indraprastha Apollo Hospitals, explains the research.
- What
- The article examines possible links between bone metabolism, osteocalcin, and glucose regulation.
- Where
- New Delhi is identified as Dr Vaishya's location.
- Why
- Researchers are investigating whether signals from bone communicate with systems involved in glucose regulation.
- Bone signal discussed
- Osteocalcin, a protein produced by bone-forming osteoblasts.
- Proposed effects
- The undercarboxylated form may influence pancreatic beta-cell function, insulin secretion, and insulin sensitivity.
- Evidence status
- Animal and cellular research is suggestive; evidence in humans is less definitive.
- Research uncertainties
- The relevant form of osteocalcin and how to measure it clinically remain uncertain.
- Diabetes and fractures
- People with type 2 diabetes have higher fragility-fracture risk, even with normal or relatively high bone mineral density.
- Shared health habits
- Resistance and weight-bearing exercise, adequate nutrition, healthy weight management, and good glucose control support both systems.
- Treatment caveat
- Osteocalcin should not be presented as an established treatment for lowering blood sugar.